Skip to main content
Log in

Trachoma

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Trachoma causes one-quarter of the world's blindness and, although it has disappeared from many developed areas, it remains a major problem, especially in underprivileged rural areas in developing countries. Recent advances in the understanding of the molecular biology of chlamydia offer encouragement for the eventual development for an effective trachoma vaccine. Advances in the understanding of the epidemiology of trachoma, particularly of the importance of reinfection and the intrafamily transmission of infection, have led to the identification of the key importance of simple hygiene measures such as facial cleanliness in preventing the transmission of trachoma. Community-based health education intervention programs are being developed to assess the efficacy of a public health approach to the control of trachomatous blindness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Danilition SL, MacLean IW, Peeling R, Winston S, Brunham RC. The 75 kilodalton protein of Chlamydia trachomatis: a member of the heat shock protein 70 family? Infect Immun 1990; 58: 189–96.

    Google Scholar 

  2. Dawson CR, Jones BR, Tarizzo ML. Epidemiology. In: Guide to trachoma control. Geneva, World Health Organization 1981: 21–4.

    Google Scholar 

  3. Grayston JT, Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 1975; 132: 87–105.

    Google Scholar 

  4. Grayston JT, Wang S-P, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7: 717–25.

    Google Scholar 

  5. Millar MI, Lane SD. Ethno-ophthalmology in the Egyptian Delta: an historical systems approach to ethnomedicine in the Middle East. Soc Sci Med 1988; 26: 651–7.

    Google Scholar 

  6. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. J Exp Med 1989; 169: 663–75.

    Google Scholar 

  7. Newhall WJV. Macromolecular and antigenic composition of chlamydiae. Chlamydia as organisms. Chapter 3. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, Inc 1988: 47–70.

    Google Scholar 

  8. Oriel JD. Chemotherapy. In: Oriel D, Ridgway G, Schachter J, Taylor-Robinson L, Ward M, eds. Chlamydial Infections, Proceedings of the Sixth International Symposium on Human Chlamydial Infections. Cambridge, Cambridge University Press 1986: 513–23.

    Google Scholar 

  9. Rank RG. Role of the immune response. Chlamydia as pathogens, Chapter 12. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, Inc 1988: 217–34.

    Google Scholar 

  10. Reacher MH, Huber MJE, Canagaratnam R, Alghassany A. A trial of surgery for trichiasis of the upper lid from trachoma. Br J Ophthalmol (in press).

  11. Schachter J. Chlamydial infections, Part 1, 2, and 3. N Engl J Med 1978; 298: 428–549.

    Google Scholar 

  12. Schachter J. Overview of human diseases. Chlamydia as pathogens, Chapter 8. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, Inc 1988: 153–65.

    Google Scholar 

  13. Schachter J, Moneada J, Dawson CR, Sheppard J, Courtright P, Said ME, Zaki S, Hafez SF, Lorincz A. Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis 1988; 158: 1347–52.

    Google Scholar 

  14. Taylor HR. Strategies for the control of trachoma. Aust NZ J Ophthalmol 1987; 15: 139–43.

    Google Scholar 

  15. Taylor HR. Trachoma research: laboratory and epidemiologic aspects. Int Rev Trach 1987: 23-58.

  16. Taylor HR, Johnson SL, Schachter J, Caldwell HD, Prendergast RA. Pathogenesis of trachoma: the stimulus for inflammation. J Immunol 1987; 38: 3023–7.

    Google Scholar 

  17. Taylor HR, Millan-Velasco F, Sommer A. The ecology of trachoma: an epidemiological study of trachoma in Southern Mexico. Bull WHO 1985; 63: 559–67.

    Google Scholar 

  18. Taylor HR, Rapoza PA, Johnson S, Muñoz B, Katala S, Mmbaga BBO, West S. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989; 30: 1823–33.

    Google Scholar 

  19. Taylor HR, Whittum-Hudson J, Schachter J, Caldwell HD, Prendergast RA. Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol Vis Sci 1988; 29: 1847–53.

    Google Scholar 

  20. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull WHO 1987; 65: 477–83.

    Google Scholar 

  21. Watkins NG, Hadlow WJ, Moos AB, Caldwell HD. Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci USA 1986; 83: 7480–4.

    Google Scholar 

  22. West S, Lynch M, Turner V, Muñoz B, Rapoza P, Mmbaga BBO, Taylor HR. Water availability and trachoma. Bull WHO 1989; 67: 71–5.

    Google Scholar 

  23. West S, Taylor HR. Community-based intervention programs for trachoma control. International Ophthalmology 1988; 12: 19–23.

    Google Scholar 

  24. Zhang YX, Stewart S, Joseph T, Taylor HR, Caldwell HD. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 1987; 138: 575–81.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Research to Prevent Blindness, William and Mary Greve International Research Scholar grant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, H.R. Trachoma. Int Ophthalmol 14, 201–204 (1990). https://doi.org/10.1007/BF00158319

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00158319

Key words

Navigation